Literature DB >> 15502931

Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea.

Patrick Ray1, Martine Arthaud, Yannick Lefort, Sophie Birolleau, Catherine Beigelman, Bruno Riou.   

Abstract

OBJECTIVE: Differentiating cardiogenic pulmonary edema (CPE) from respiratory causes of dyspnea is particularly difficult in elderly patients. The aim of our study was to evaluate B-type natriuretic peptide (BNP) in patients older than 65 years presenting with acute dyspnea.
DESIGN: Prospective study.
SETTING: Medical emergency department of a 2000-bed urban teaching hospital. PATIENTS: Patients aged over 65 years presenting with acute dyspnea and a respiratory rate more than 25/min or a PaO(2) below 70 mmHg, SpO(2 )less than 92%, PaCO(2) higher than 45 mmHg with pH less than 7.35, were included. BNP levels, measured blind at admission were compared with the final diagnosis (CPE or no CPE) as defined by experts. INTERVENTION: None. MEASUREMENTS AND
RESULTS: Three hundred eight patients (mean age of 80 years) were enrolled in the study. The median BNP was 575 pg/ml [95% confidence interval (CI): 410-898] in the CPE group (n=141) versus 75 pg/ml (95% CI: 59-98) in the no CPE group (n=167) (p<0.001). The best threshold value of BNP was 250 pg/ml, with a sensitivity and specificity for CPE of 0.78 (95% CI: 0.71-0.84) and 0.90 (95% CI: 0.84-0.93), respectively. The area under the ROC curve was 0.874+/-0.081 (p<0.001). The accuracy of BNP-assisted diagnosis was higher than that of the emergency physician (0.84 versus 0.77, p<0.05).
CONCLUSION: Analysis of BNP is useful in elderly patients with acute dyspnea, but the threshold value is higher than that previously determined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502931     DOI: 10.1007/s00134-004-2469-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

Review 1.  A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis.

Authors:  Joachim E Fischer; Lucas M Bachmann; Roman Jaeschke
Journal:  Intensive Care Med       Date:  2003-05-07       Impact factor: 17.440

2.  Effects of prehospital medications on mortality and length of stay in congestive heart failure.

Authors:  R C Wuerz; S A Meador
Journal:  Ann Emerg Med       Date:  1992-06       Impact factor: 5.721

3.  Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.

Authors:  A S Maisel; J Koon; P Krishnaswamy; R Kazenegra; P Clopton; N Gardetto; R Morrisey; A Garcia; A Chiu; A De Maria
Journal:  Am Heart J       Date:  2001-03       Impact factor: 4.749

4.  Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons.

Authors:  Ryuji Ueda; Masatoshi Yokouchi; Takaomi Suzuki; Eiichi Otomo; Takashi Katagiri
Journal:  Am J Med       Date:  2003-03       Impact factor: 4.965

5.  Autopsy study of the elderly institutionalized patient. Review of 234 autopsies.

Authors:  J S Gross; R R Neufeld; L S Libow; I Gerber; M Rodstein
Journal:  Arch Intern Med       Date:  1988-01

6.  Brain natriuretic peptide predicts mortality in the elderly.

Authors:  T Wallén; S Landahl; T Hedner; K Nakao; Y Saito
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

7.  Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease.

Authors:  Y Yamada; J Goto; M Yokota
Journal:  Cardiology       Date:  1997 Sep-Oct       Impact factor: 1.869

8.  Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea.

Authors:  Damien Logeart; Carole Saudubray; Pascale Beyne; Gabriel Thabut; Pierre-Vladimir Ennezat; Christophe Chavelas; Caroline Zanker; Erik Bouvier; Alain Cohen Solal
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

Review 9.  Brain natriuretic peptide in the management of heart failure: the versatile neurohormone.

Authors:  Simon de Denus; Chantal Pharand; David R Williamson
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

10.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

View more
  8 in total

Review 1.  Year in review in intensive care medicine, 2004. II. Brain injury, hemodynamic monitoring and treatment, pulmonary embolism, gastrointestinal tract, and renal failure.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

Review 2.  Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.

Authors:  Stephen A Hill; Ronald A Booth; P Lina Santaguida; Andrew Don-Wauchope; Judy A Brown; Mark Oremus; Usman Ali; Amy Bustamam; Nazmul Sohel; Robert McKelvie; Cynthia Balion; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

Review 3.  Heart failure in the elderly: ten peculiar management considerations.

Authors:  Feras Bader; Bassam Atallah; Lisa F Brennan; Rola H Rimawi; Mohammed E Khalil
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 4.  Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

Authors:  Jun R Chiong; Geoffrey T Jao; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

Review 5.  The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting.

Authors:  Emmert Roberts; Andrew J Ludman; Katharina Dworzynski; Abdallah Al-Mohammad; Martin R Cowie; John J V McMurray; Jonathan Mant
Journal:  BMJ       Date:  2015-03-04

6.  Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.

Authors:  S Delerme; C Chenevier-Gobeaux; B Doumenc; P Ray
Journal:  Biomark Insights       Date:  2008-03-27

7.  The utility of B-type natriuretic peptide in the diagnosis of heart failure in the emergency department: a systematic review.

Authors:  Deborah Korenstein; Juan P Wisnivesky; Peter Wyer; Rhodes Adler; Diego Ponieman; Thomas McGinn
Journal:  BMC Emerg Med       Date:  2007-06-26

Review 8.  The Indian Consensus Document on cardiac biomarker.

Authors:  I Satyamurthy; Jamshed J Dalal; J P S Sawhney; J C Mohan; Shubha A Chogle; Nagaraj Desai; Shireesh P Sathe; Alan S Maisel
Journal:  Indian Heart J       Date:  2014 Jan-Feb
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.